Small Cell Lung Cancer Extensive Stage Clinical Trials
0 recruiting
Showing 1–13 of 13 trials
Recruiting
Phase 1Phase 2
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC170 enrolled2 locationsNCT07227597
Recruiting
Phase 2
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
Small Cell Lung Cancer Extensive Stage
Sichuan University202 enrolled1 locationNCT06610734
Recruiting
Phase 1
Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)
Solid Tumor, AdultBrain MetastasesSmall Cell Lung Cancer Extensive Stage
University of Texas Southwestern Medical Center45 enrolled1 locationNCT07139990
Recruiting
Phase 1Phase 2
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Small Cell Lung Cancer Extensive Stage
Genprex, Inc.62 enrolled17 locationsNCT05703971
Recruiting
Phase 3
A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Small Cell Lung Cancer Extensive Stage
Qilu Pharmaceutical Co., Ltd.450 enrolled1 locationNCT06954246
Recruiting
Phase 2
PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer
Small Cell Lung Cancer Extensive Stage
Nanfang Hospital, Southern Medical University40 enrolled1 locationNCT06429696
Recruiting
Phase 1
DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
Small Cell Lung Cancer Extensive StageLarge Cell Neuroendocrine Carcinoma of the Lung
Legend Biotech USA Inc41 enrolled4 locationsNCT05680922
Recruiting
Phase 1
Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC
Small Cell Lung Cancer Extensive Stage
Sichuan University28 enrolled1 locationNCT06348797
Recruiting
Phase 1Phase 2
IN10018 Combination Therapy in Treatment-naïve ES-SCLC
Small Cell Lung Cancer Extensive Stage
InxMed (Shanghai) Co., Ltd.120 enrolled3 locationsNCT06030258
Recruiting
Phase 2
Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer
Small Cell Lung Cancer Extensive Stage
Fundación GECP46 enrolled18 locationsNCT05384015
Recruiting
Phase 2
First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC
Small Cell Lung Cancer Extensive Stage
Xiaorong Dong45 enrolled1 locationNCT05745350
Recruiting
Phase 2
Liposomal Irinotecan and Apatinib in ES-SCLC
Small Cell Lung Cancer Extensive Stage
Second Affiliated Hospital, School of Medicine, Zhejiang University30 enrolled1 locationNCT06749691
Recruiting
Phase 2
Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC
Small Cell Lung Cancer Extensive Stage
Guangzhou Institute of Respiratory Disease120 enrolled1 locationNCT06739928